Results 221 to 230 of about 955,664 (289)

Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis

open access: yesArthritis &Rheumatology, Volume 78, Issue 11, Page 2189-2202, November 2026.
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo   +7 more
wiley   +1 more source

[Corticosteroids in the treatment of respiratory hypersensitivity].

open access: yesTidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1977
openaire   +1 more source

Oritavancin safety: a real-world pharmacovigilance study of the FAERS database. [PDF]

open access: yesFront Cell Infect Microbiol
Xie B, Zhou YF, Song HC, Cui XJ.
europepmc   +1 more source

A needle in a haystack: Navigating equine injectable drug reactions

open access: yes
Equine Veterinary Education, Volume 38, Issue 12, Page 630-633, December 2026.
G. D. Hallowell
wiley   +1 more source

Home - About - Disclaimer - Privacy